{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:01:55Z","timestamp":1790622115694,"version":"4.1.0"},"reference-count":116,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.jaad.2013.01.033","type":"journal-article","created":{"date-parts":[[2013,4,18]],"date-time":"2013-04-18T05:29:01Z","timestamp":1366262941000},"page":"693.e1-693.e14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":374,"title":["DRESS syndrome"],"prefix":"10.1016","volume":"68","author":[{"given":"Zain","family":"Husain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobby Y.","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A.","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2013.01.033_bib1","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1525-1470.2009.00870.x","article-title":"Retrospective analysis of 32 pediatric patients with anticonvulsant hypersensitivity syndrome (ACHSS)","volume":"26","author":"Newell","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib2","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1345\/aph.10284","article-title":"Antiepileptic hypersensitivity syndrome in children","volume":"35","author":"Bessmertny","year":"2001","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.jaad.2013.01.033_bib3","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM195006082422304","article-title":"Dilantin sensitivity; report of a case of hepatitis with jaundice, pyrexia and exfoliative dermatitis","volume":"242","author":"Chaiken","year":"1950","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2013.01.033_bib4","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/1097-0142(195901\/02)12:1<164::AID-CNCR2820120122>3.0.CO;2-Y","article-title":"Lymphadenopathy induced by anticonvulsant drugs and mimicking clinically pathologically malignant lymphomas","volume":"12","author":"Saltzstein","year":"1959","journal-title":"Cancer"},{"key":"10.1016\/j.jaad.2013.01.033_bib5","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/S1085-5629(96)80038-1","article-title":"Drug-induced pseudolymphoma and drug hypersensitivity syndrome (drug rash with eosinophilia and systemic symptoms: DRESS)","volume":"15","author":"Bocquet","year":"1996","journal-title":"Semin Cutan Med Surg"},{"key":"10.1016\/j.jaad.2013.01.033_bib6","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1159\/000095437","article-title":"Drug rash with eosinophilia and systemic symptoms versus Stevens\u2013Johnson syndrome\u2014a case that indicates a stumbling block in the current classification","volume":"141","author":"Wolf","year":"2006","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.jaad.2013.01.033_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1745-6673-1-9","article-title":"The dapsone hypersensitivity syndrome revisited: a potentially fatal multisystem disorder with prominent hepatopulmonary manifestations","volume":"1","author":"Kosseifi","year":"2006","journal-title":"J Occup Med Toxicol"},{"key":"10.1016\/j.jaad.2013.01.033_bib8","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.2146\/ajhp050175","article-title":"Possible drug rash with eosinophilia and systemic symptoms syndrome after exposure to epoetin alfa","volume":"62","author":"Norgard","year":"2005","journal-title":"Am J Health Syst Pharm"},{"key":"10.1016\/j.jaad.2013.01.033_bib9","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/j.1468-3083.2007.02490.x","article-title":"Probable drug rash with eosinophilia and systemic symptoms syndrome related to tetrazepam","volume":"22","author":"Bachmeyer","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2013.01.033_bib10","first-page":"50","article-title":"DRESS syndrome caused by efalizumab","volume":"33","author":"White","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib11","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s10067-007-0772-1","article-title":"Hydroxychloroquine-induced DRESS syndrome","volume":"27","author":"Volpe","year":"2008","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib12","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/j.clinthera.2009.03.011","article-title":"Drug rash with eosinophilia and systemic signs syndrome in a patient with multiple sclerosis","volume":"31","author":"Caruso","year":"2009","journal-title":"Clin Ther"},{"key":"10.1016\/j.jaad.2013.01.033_bib13","doi-asserted-by":"crossref","first-page":"2940","DOI":"10.1093\/ndt\/gfp277","article-title":"A case of sulphasalazine-induced DRESS syndrome with delayed acute interstitial nephritis","volume":"24","author":"Augusto","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.jaad.2013.01.033_bib14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/ageing\/afq026","article-title":"Severe exfoliative dermatitis caused by strontium ranelate: two cases of a new drug reaction","volume":"39","author":"Smith","year":"2010","journal-title":"Age Ageing"},{"key":"10.1016\/j.jaad.2013.01.033_bib15","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000142729","article-title":"Vancomycin-induced DRESS syndrome in a female patient","volume":"82","author":"Vauthey","year":"2008","journal-title":"Pharmacology"},{"key":"10.1016\/j.jaad.2013.01.033_bib16","doi-asserted-by":"crossref","first-page":"e17","DOI":"10.1053\/j.ajkd.2009.07.013","article-title":"Linezolid-associated acute interstitial nephritis and drug rash with eosinophilia and systemic symptoms (DRESS) syndrome","volume":"54","author":"Savard","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.jaad.2013.01.033_bib17","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1752-1947-1-22","article-title":"Minocycline-induced hypersensitivity syndrome presenting with meningitis and brain edema: a case report","volume":"1","author":"Lefebvre","year":"2007","journal-title":"J Med Case Rep"},{"key":"10.1016\/j.jaad.2013.01.033_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaad.2009.05.046","article-title":"Minocycline-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome with persistent myocarditis","volume":"62","author":"Shaughnessy","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib19","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3346\/jkms.2008.23.3.521","article-title":"Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome induced by celecoxib and anti-tuberculosis drugs","volume":"23","author":"Lee","year":"2008","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jaad.2013.01.033_bib20","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/j.1442-200X.2008.02603.x","article-title":"Drug rash with eosinophilia and systemic symptoms induced by cefotaxime and ampicillin","volume":"50","author":"Fujiwaki","year":"2008","journal-title":"Pediatr Int"},{"key":"10.1016\/j.jaad.2013.01.033_bib21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1080\/08860220701861045","article-title":"Allopurinol-induced recurrent DRESS syndrome: pathophysiology and treatment","volume":"30","author":"Shalom","year":"2008","journal-title":"Ren Fail"},{"key":"10.1016\/j.jaad.2013.01.033_bib22","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00002826-200307000-00004","article-title":"Drug rash with eosinophilia and systemic symptoms secondary to phenobarbitone","volume":"26","author":"Baruzzi","year":"2003","journal-title":"Clin Neuropharmacol"},{"key":"10.1016\/j.jaad.2013.01.033_bib23","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S1081-1206(10)61853-4","article-title":"Drug-induced rash with eosinophilia and systemic symptoms syndrome with bupropion administration","volume":"90","author":"Bagshaw","year":"2003","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jaad.2013.01.033_bib24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/00015550310005915","article-title":"Drug-induced eosinophilia and multisystemic failure with positive patch-test reaction to spironolactone: DRESS syndrome","volume":"84","author":"Ghislain","year":"2004","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2013.01.033_bib25","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1080\/00015550310006095","article-title":"Drug rash with eosinophilia and systemic symptoms (DRESS) due to streptomycin","volume":"84","author":"Passeron","year":"2004","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2013.01.033_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tox.2004.12.022","article-title":"Clinical heterogeneity of drug hypersensitivity","volume":"209","author":"Roujeau","year":"2005","journal-title":"Toxicol"},{"key":"10.1016\/j.jaad.2013.01.033_bib27","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/j.1468-3083.2008.02585.x","article-title":"Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan","volume":"22","author":"Chiou","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2013.01.033_bib28","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/17843286.1999.11754231","article-title":"Drug rash with eosinophilia and systemic symptoms (DRESS syndrome)","volume":"54","author":"Tas","year":"1999","journal-title":"Acta Clin Belg"},{"key":"10.1016\/j.jaad.2013.01.033_bib29","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0190-9622(97)80414-8","article-title":"Fever, lymphadenopathy, eosinophilia, lymphocytosis, hepatitis, and dermatitis: a severe adverse reaction to minocycline","volume":"36","author":"MacNeil","year":"1997","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib30","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1159\/000069956","article-title":"Management of drug rash with eosinophilia and systemic symptoms (DRESS syndrome): an update","volume":"206","author":"Tas","year":"2003","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2013.01.033_bib31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4168\/aair.2010.2.2.123","article-title":"Comparison of the causes and clinical features of drug rash with eosinophilia and systemic symptoms and stevens-johnson syndrome","volume":"2","author":"Jeung","year":"2010","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jaad.2013.01.033_bib32","first-page":"142","article-title":"Severe drug-induced skin reactions: clinical pattern, diagnostics and therapy","volume":"7","author":"Mockenhaupt","year":"2009","journal-title":"J Dtsch Dermatol Ges"},{"key":"10.1016\/j.jaad.2013.01.033_bib33","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/MD.0b013e3181a4d1a1","article-title":"Drug-induced hypersensitivity syndrome: clinical and biologic disease patterns in 24 patients","volume":"88","author":"Ben m'rad","year":"2009","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jaad.2013.01.033_bib34","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2165\/00002018-199921060-00005","article-title":"Anticonvulsant hypersensitivity syndrome: incidence, prevention and management","volume":"21","author":"Knowles","year":"1999","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaad.2013.01.033_bib35","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1001\/archinte.1995.00430210033005","article-title":"Anticonvulsant hypersensitivity syndrome","volume":"155","author":"Vittorio","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaad.2013.01.033_bib36","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/archderm.1996.03890320082013","article-title":"Serious adverse reactions induced by minocycline. Report of 13 patients and review of the literature","volume":"132","author":"Knowles","year":"1996","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib37","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0151-9638(04)93600-9","article-title":"Drug hypersensitivity syndrome: DRESS (drug reaction with eosinophilia and systemic symptoms) [in French]","volume":"131","author":"Begon","year":"2004","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaad.2013.01.033_bib38","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/sj.bjp.0704074","article-title":"Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism-dependent haptenation and T-cell proliferation in\u00a0vivo","volume":"133","author":"Naisbitt","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jaad.2013.01.033_bib39","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1365-2133.2006.07284.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"155","author":"Peyri\u00e8re","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib40","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1056\/NEJMoa0706135","article-title":"HLA-B*5701 screening for hypersensitivity to abacavir","volume":"358","author":"Mallal","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2013.01.033_bib41","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(00)03137-8","article-title":"Idiosyncratic drug reactions: the reactive metabolite syndromes","volume":"356","author":"Knowles","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.jaad.2013.01.033_bib42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1124\/jpet.103.050112","article-title":"Characterization of sulfamethoxazole and sulfamethoxazole metabolite-specific T-cell responses in animals and humans","volume":"306","author":"Farrell","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jaad.2013.01.033_bib43","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1124\/mol.63.3.732","article-title":"Hypersensitivity reactions to carbamazepine: characterization of the specificity, phenotype, and cytokine profile of drug-specific T cell clones","volume":"63","author":"Naisbitt","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jaad.2013.01.033_bib44","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2169\/internalmedicine.49.2451","article-title":"Acute kidney injury caused by zonisamide-induced hypersensitivity syndrome","volume":"49","author":"Fujita","year":"2010","journal-title":"Intern Med"},{"key":"10.1016\/j.jaad.2013.01.033_bib45","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1080\/15563650802342104","article-title":"Oxcarbazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS)","volume":"46","author":"D\u2019Orazio","year":"2008","journal-title":"Clin Toxicol (Phila)"},{"key":"10.1016\/j.jaad.2013.01.033_bib46","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/j.1365-4632.2008.03637.x","article-title":"Carbamazepine-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: report of four cases and brief review","volume":"47","author":"Ganeva","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib47","doi-asserted-by":"crossref","first-page":"768","DOI":"10.3346\/jkms.2006.21.4.768","article-title":"Drug hypersensitivity to previously tolerated phenytoin by carbamazepine-induced DRESS syndrome","volume":"21","author":"Kim","year":"2006","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jaad.2013.01.033_bib48","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/j.1368-5031.2005.00550.x","article-title":"Carbamazepine-induced acute liver failure as part of the DRESS syndrome","volume":"59","author":"Syn","year":"2005","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jaad.2013.01.033_bib49","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1111\/j.1365-2230.2010.03820.x","article-title":"Differences in immunological alterations and underlying viral infections in two well-defined severe drug eruptions","volume":"35","author":"Hirahara","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib50","first-page":"5","article-title":"Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome","volume":"8","author":"Ghislain","year":"2002","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jaad.2013.01.033_bib51","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1111\/j.1365-2230.2008.02823.x","article-title":"Drug rash with eosinophilia and systemic symptoms and graft-versus-host disease developing sequentially in a patient","volume":"34","author":"Natkunarajah","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1600-0536.2009.01659.x","article-title":"Epicutaneous patch testing in drug hypersensitivity syndrome (DRESS)","volume":"62","author":"Santiago","year":"2010","journal-title":"Contact Derm"},{"key":"10.1016\/j.jaad.2013.01.033_bib53","first-page":"301","article-title":"Association of human herpesvirus 6 infection with drug reaction with eosinophilia and systemic symptoms","volume":"137","author":"Descamps","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib54","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1365-2710.2009.01081.x","article-title":"DRESS-syndrome on sulfasalazine and naproxen treatment for juvenile idiopathic arthritis and reactivation of human herpevirus 6 in an 11-year-old Caucasian boy","volume":"35","author":"Pi\u00f1ana","year":"2010","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/j.jaad.2013.01.033_bib55","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1172\/JCI113798","article-title":"Anticonvulsant hypersensitivity syndrome. In\u00a0vitro assessment of risk","volume":"82","author":"Shear","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jaad.2013.01.033_bib56","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1111\/j.1365-2133.2003.05584.x","article-title":"A 6-month prospective survey of cutaneous drug reactions in a hospital setting","volume":"149","author":"Fiszenson-Albala","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib57","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1592\/phco.27.10.1425","article-title":"Anticonvulsant hypersensitivity syndrome: implications for pharmaceutical care","volume":"27","author":"Bohan","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jaad.2013.01.033_bib58","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s12016-007-8010-9","article-title":"A complex interaction between drug allergy and viral infection","volume":"33","author":"Shiohara","year":"2007","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.jaad.2013.01.033_bib59","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.amjmed.2011.01.017","article-title":"The DRESS syndrome: a literature review","volume":"124","author":"Cacoub","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2013.01.033_bib60","first-page":"357","article-title":"The drug hypersensitivity syndrome: what is the pathogenesis?","volume":"137","author":"Sullivan","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib61","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2165\/00023210-199912030-00005","article-title":"Anticonvulsant-induced cutaneous reactions, incidence, mechanisms and management","volume":"12","author":"Ruble","year":"1999","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jaad.2013.01.033_bib62","first-page":"433","article-title":"Use of the lymphocyte transformation test in the diagnosis of DRESS syndrome induced by ceftriaxone and piperacillin-tazobactam: two case reports","volume":"20","author":"Jurado-Palomo","year":"2010","journal-title":"J Invest Allergol Clin Immunol"},{"key":"10.1016\/j.jaad.2013.01.033_bib63","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1067\/mai.2003.1507","article-title":"Characterization of drug-specific T cells in lamotrigine hypersensitivity","volume":"111","author":"Naisbitt","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2013.01.033_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2332\/allergolint.55.1","article-title":"Drug-induced hypersensitivity syndrome (DIHS): a reaction induced by a complex interplay among herpesviruses and antiviral and antidrug immune responses","volume":"55","author":"Shiohara","year":"2006","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaad.2013.01.033_bib65","doi-asserted-by":"crossref","first-page":"46ra62","DOI":"10.1126\/scitranslmed.3001116","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response","volume":"2","author":"Picard","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jaad.2013.01.033_bib66","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.eplepsyres.2006.02.006","article-title":"Association of anticonvulsant hypersensitivity syndrome with herpesvirus 6, 7","volume":"70","author":"Oskay","year":"2006","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.jaad.2013.01.033_bib67","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2133.2006.07332.x","article-title":"Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome","volume":"155","author":"Seishima","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib68","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1365-2133.2006.07238.x","article-title":"Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease","volume":"155","author":"Kano","year":"2006","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib69","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jaci.2006.03.005","article-title":"Activation of T cells by carbamazepine and carbamazepine metabolites","volume":"118","author":"Wu","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2013.01.033_bib70","doi-asserted-by":"crossref","first-page":"9788","DOI":"10.1073\/pnas.93.18.9788","article-title":"In\u00a0vitro activation of human herpesviruses 6 and 7 from latency","volume":"93","author":"Katsafanas","year":"1996","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jaad.2013.01.033_bib71","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1001\/archderm.140.2.183","article-title":"Association between anticonvulsant hypersensitivity syndrome and human herpesvirus 6 reactivation and hypogammaglobulinemia","volume":"140","author":"Kano","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib72","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-2334-10-49","article-title":"Is the drug-induced hypersensitivity syndrome (DIHS) due to human herpesvirus 6 infection or to allergy-mediated viral reactivation? Report of a case and literature review","volume":"10","author":"Gentile","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.jaad.2013.01.033_bib73","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0002-9343(91)90216-K","article-title":"Familial occurrence of hypersensitivity to phenytoin","volume":"91","author":"Gennis","year":"1991","journal-title":"Am J Med"},{"key":"10.1016\/j.jaad.2013.01.033_bib74","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/j.1365-2133.2007.08382.x","article-title":"Chromosomal integration of human herpesvirus 6 DNA in anticonvulsant hypersensitivity syndrome","volume":"158","author":"Watanabe","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib75","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1046\/j.1365-2133.2003.05368.x","article-title":"Carbamazepine-induced hypersensitivity syndrome associated with transient hypogammaglobulinaemia and reactivation of human herpesvirus 6 infection demonstrated by real-time quantitative polymerase chain reaction","volume":"149","author":"Aihara","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib76","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/01.fpc.0000199500.46842.4a","article-title":"Genetic susceptibility to carbamazepine-induced cutaneous adverse drug reactions","volume":"16","author":"Hung","year":"2006","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.jaad.2013.01.033_bib77","doi-asserted-by":"crossref","first-page":"813","DOI":"10.2217\/14622416.7.6.813","article-title":"HLA-B locus in Caucasian patients with carbamazepine hypersensitivity","volume":"7","author":"Alfirevic","year":"2006","journal-title":"Pharmacogenomics"},{"issue":"suppl 1","key":"10.1016\/j.jaad.2013.01.033_bib78","doi-asserted-by":"crossref","first-page":"S92","DOI":"10.1016\/S1386-6532(06)70019-1","article-title":"Human herpesvirus 6 reactivation and inflammatory cytokine production in patients with drug-induced hypersensitivity syndrome","volume":"37","author":"Yoshikawa","year":"2006","journal-title":"J Clin Virol"},{"key":"10.1016\/j.jaad.2013.01.033_bib79","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1346-8138.2010.01176.x","article-title":"New aspects of drug-induced hypersensitivity syndrome","volume":"38","author":"Tohyama","year":"2011","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib80","doi-asserted-by":"crossref","first-page":"8071","DOI":"10.4049\/jimmunol.0804002","article-title":"Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome","volume":"182","author":"Takahashi","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.jaad.2013.01.033_bib81","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.jaci.2010.06.004","article-title":"Fluctuation of blood and skin plasmacytoid dendritic cells in drug-induced hypersensitivity syndrome","volume":"126","author":"Sugita","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2013.01.033_bib82","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1126\/science.284.5421.1835","article-title":"The nature of the principal type 1 interferon-producing cells in human blood","volume":"284","author":"Siegal","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jaad.2013.01.033_bib83","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/ni1141","article-title":"Plasmacytoid dendritic cells in immunity","volume":"5","author":"Colonna","year":"2004","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jaad.2013.01.033_bib84","series-title":"Epidemiology and causes of drug hypersensitivity","author":"Demoly","year":"2007"},{"key":"10.1016\/j.jaad.2013.01.033_bib85","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1346-8138.2010.01196.x","article-title":"Pharmacogenetics of cutaneous adverse drug reactions","volume":"38","author":"Aihara","year":"2011","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib86","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/archderm.1995.01690170046006","article-title":"Metabolic predisposition to cutaneous adverse drug reactions. Role in toxic epidermal necrolysis caused by sulfonamides and anticonvulsants","volume":"131","author":"Wolkenstein","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib87","doi-asserted-by":"crossref","first-page":"179","DOI":"10.7326\/0003-4819-105-2-179","article-title":"Differences in metabolism of sulfonamides predisposing to idiosyncratic toxicity","volume":"105","author":"Shear","year":"1986","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaad.2013.01.033_bib88","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1136\/gut.29.9.1153","article-title":"Glutathione deficiency in alcoholics: risk factor for paracetamol hepatotoxicity","volume":"29","author":"Lauterburg","year":"1988","journal-title":"Gut"},{"key":"10.1016\/j.jaad.2013.01.033_bib89","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1046\/j.1365-2133.1998.02559.x","article-title":"Increased levels of interleukin 5 are associated with the generation of eosinophilia in drug-induced hypersensitivity syndrome","volume":"139","author":"Choquet-Kastylevsky","year":"1998","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib90","doi-asserted-by":"crossref","first-page":"706","DOI":"10.4049\/jimmunol.149.2.706","article-title":"Drug-specific T cells derived from patients with drug-induced allergic hepatitis","volume":"149","author":"Tsutsui","year":"1992","journal-title":"J Immunol"},{"issue":"1 suppl","key":"10.1016\/j.jaad.2013.01.033_bib91","doi-asserted-by":"crossref","first-page":"95S","DOI":"10.1038\/jid.1995.19","article-title":"Lymphocyte activation in cutaneous drug reactions","volume":"105","author":"Hertl","year":"1995","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib92","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1111\/j.1600-6143.2009.02788.x","article-title":"Fulminant liver failure after vancomycin in a sulfasalazine-induced DRESS syndrome: fatal recurrence after liver transplantation","volume":"9","author":"Mennicke","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jaad.2013.01.033_bib93","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1590\/S0365-05962012000300013","article-title":"Drug reaction with eosinophilia and systemic symptoms (DRESS)\/drug-induced hypersensitivity syndrome (DIHS): a review of current concepts","volume":"87","author":"Criado","year":"2012","journal-title":"An Bras Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib94","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/00130832-200108000-00003","article-title":"Physiopathology and treatment of severe drug eruptions","volume":"1","author":"Bachot","year":"2001","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2013.01.033_bib95","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1067\/mai.2000.110922","article-title":"Evidence for a role for IL-5 and eotaxin in activating and recruiting eosinophils in drug-induced cutaneous eruptions","volume":"106","author":"Yawalkar","year":"2000","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaad.2013.01.033_bib96","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1346-8138.2008.00548.x","article-title":"Human leukocyte antigen genotypes in carbamazepine-induced severe cutaneous adverse drug response in Japanese patients","volume":"35","author":"Kashiwagi","year":"2008","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib97","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.56.7.890","article-title":"TNFalpha promoter region gene polymorphisms in carbamazepine-hypersensitive patients","volume":"56","author":"Pirmohamed","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jaad.2013.01.033_bib98","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1001\/archderm.134.9.1108","article-title":"Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome","volume":"134","author":"Suzuki","year":"1998","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib99","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1111\/j.1365-2133.2007.08167.x","article-title":"Association of human herpesvirus 6 reactivation with the flaring and severity of drug-induced hypersensitivity syndrome","volume":"157","author":"Tohyama","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib100","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1001\/archdermatol.2007.48","article-title":"Toxic epidermal necrolysis due to zonisamide associated with reactivation of human herpesvirus 6","volume":"144","author":"Teraki","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib101","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1097\/DAD.0b013e3181a18d64","article-title":"Drug-induced hypersensitivity syndrome with superficial granulomatous dermatitis\u2014a novel finding","volume":"31","author":"Fernando","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.jaad.2013.01.033_bib102","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.mcna.2010.03.004","article-title":"Visceral involvements and long-term sequelae in drug-induced hypersensitivity syndrome","volume":"94","author":"Kano","year":"2010","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.jaad.2013.01.033_bib103","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jaad.2009.08.050","article-title":"Retrospective analysis of drug-induced hypersensitivity syndrome: a study of 27 patients","volume":"63","author":"Ang","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib104","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.iac.2009.04.007","article-title":"The variable clinical picture of drug-induced hypersensitivity syndrome\/drug rash with eosinophilia and systemic symptoms in relation to the eliciting drug","volume":"29","author":"Kano","year":"2009","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaad.2013.01.033_bib105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1471-230X-3-21","article-title":"Dapsone induced cholangitis as a part of dapsone syndrome: a case report","volume":"3","author":"Itha","year":"2003","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.jaad.2013.01.033_bib106","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJM199411103311906","article-title":"Severe adverse cutaneous reactions to drugs","volume":"331","author":"Roujeau","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaad.2013.01.033_bib107","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.jaad.2010.12.013","article-title":"Fulminant myocarditis as a late sequela of DRESS: two cases","volume":"65","author":"Bourgeois","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib108","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.10194","article-title":"Human herpesvirus 6 encephalitis associated with hypersensitivity syndrome","volume":"51","author":"Fujino","year":"2002","journal-title":"Ann Neurol"},{"key":"10.1016\/j.jaad.2013.01.033_bib109","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2230.2007.02645.x","article-title":"Syndrome of inappropriate secretion of antidiuretic hormone associated with limbic encephalitis in a patient with drug-induced hypersensitivity syndrome","volume":"33","author":"Sakuma","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib110","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2169\/internalmedicine.40.331","article-title":"Allopurinol hypersensitivity syndrome associated with systemic cytomegalovirus infection and systemic bacteremia","volume":"40","author":"Arakawa","year":"2001","journal-title":"Intern Med"},{"key":"10.1016\/j.jaad.2013.01.033_bib111","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1365-2133.2006.07704.x","article-title":"Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist?","volume":"156","author":"Kardaun","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib112","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/j.1464-5491.2004.01307.x","article-title":"A case of fulminant Type 1 diabetes associated with mexiletine hypersensitivity syndrome","volume":"21","author":"Seino","year":"2004","journal-title":"Diabet Med"},{"issue":"2 suppl","key":"10.1016\/j.jaad.2013.01.033_bib113","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1016\/j.jaad.2005.03.057","article-title":"Fulminant type 1 diabetes mellitus caused by drug hypersensitivity syndrome with human herpesvirus 6 infection","volume":"54","author":"Chiou","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib114","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/archinte.162.10.1190","article-title":"Allopurinol hypersensitivity syndrome associated with pancreatic exocrine abnormalities and new-onset diabetes mellitus","volume":"162","author":"Sommers","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaad.2013.01.033_bib115","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2165\/00128071-200304080-00006","article-title":"Differential diagnosis of severe cutaneous drug eruptions","volume":"4","author":"Bachot","year":"2003","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jaad.2013.01.033_bib116","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1111\/j.1365-2133.2007.07807.x","article-title":"The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations","volume":"156","author":"Shiohara","year":"2007","journal-title":"Br J Dermatol"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962213001540?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962213001540?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:25:56Z","timestamp":1759271156000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962213001540"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":116,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S0190962213001540"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2013.01.033","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DRESS syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2013.01.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}